Tango Therapeutics, Inc. (TNGX) is a clinical-stage biopharmaceutical company focused on discovering and developing novel cancer therapeutics. The company utilizes a synthetic lethality approach to identify and target genetic vulnerabilities in cancer cells. Tango's pipeline includes targeted therapies aimed at specific oncology indications, with programs advancing through preclinical and clinical development stages.
expected 2026-11-10
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-05 | 2025-12-31 | 0001193125-26-092518 | EDGAR | 97K words |
| 2025-02-27 | 2024-12-31 | 0000950170-25-028353 | EDGAR | 95K words |
| 2024-03-18 | 2023-12-31 | 0000950170-24-032516 | EDGAR | 94K words |
| 2023-03-27 | 2022-12-31 | 0000950170-23-009854 | EDGAR | 95K words |
| 2022-03-28 | 2021-12-31 | 0000950170-22-004721 | EDGAR | — |
| 2021-03-31 | 2020-12-31 | 0001213900-21-019249 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-11 | 2026-06-30 | 0001193125-26-343424 | EDGAR | 25K words |
| 2025-11-04 | 2025-09-30 | 0001193125-25-263680 | EDGAR | 29K words |
| 2025-08-05 | 2025-06-30 | 0000950170-25-102392 | EDGAR | 27K words |
| 2025-05-12 | 2025-03-31 | 0000950170-25-068549 | EDGAR | 23K words |
| 2024-11-06 | 2024-09-30 | 0000950170-24-121818 | EDGAR | 24K words |
| 2024-08-07 | 2024-06-30 | 0000950170-24-092274 | EDGAR | 24K words |
| 2024-05-08 | 2024-03-31 | 0000950170-24-055065 | EDGAR | 22K words |
| 2023-11-08 | 2023-09-30 | 0000950170-23-060682 | EDGAR | 25K words |
| 2023-08-07 | 2023-06-30 | 0000950170-23-038750 | EDGAR | 24K words |
| 2023-05-09 | 2023-03-31 | 0000950170-23-019140 | EDGAR | 22K words |
| 2022-11-10 | 2022-09-30 | 0000950170-22-024219 | EDGAR | 69K words |
| 2022-08-10 | 2022-06-30 | 0000950170-22-016257 | EDGAR | 68K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-11 | 0001193125-26-343434 | EDGAR | 3K words |
| 2026-08-11 | 0001193125-26-344997 | EDGAR | 1K words |
| 2026-08-06 | 0001193125-26-338480 | EDGAR | 1K words |
| 2026-03-05 | 0001193125-26-092535 | EDGAR | 3K words |
| 2026-01-08 | 0001193125-26-007086 | EDGAR | 3K words |
| 2026-01-05 | 0001193125-26-001495 | EDGAR | 1K words |
| 2025-11-21 | 0001193125-25-290679 | EDGAR | 1K words |
| 2025-11-04 | 0001193125-25-263684 | EDGAR | 4K words |
| 2025-10-24 | 0001193125-25-249302 | EDGAR | 22K words |
| 2025-10-23 | 0001193125-25-247658 | EDGAR | 3K words |
78 total filings indexed. 50 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001819133 |
| Ticker | TNGX |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.tangotx.com |
| Listed | 2021-08-11 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/TNGX (~200 tokens, structured JSON with cryptographic provenance)